Literature DB >> 25329696

RBP-J imposes a requirement for ITAM-mediated costimulation of osteoclastogenesis.

Susan Li, Christine H Miller, Eugenia Giannopoulou, Xiaoyu Hu, Lionel B Ivashkiv, Baohong Zhao.   

Abstract

Osteoclastogenesis requires activation of RANK signaling as well as costimulatory signals from immunoreceptor tyrosine-based activation motif-containing (ITAM-containing) receptors/adaptors, predominantly tyrosine kinase-binding proteins DAP12 and FcRγ, in osteoclast precursors. It is not well understood how costimulatory signals are regulated and integrated with RANK signaling. Here, we found that osteopetrotic bone phenotypes in mice lacking DAP12 or DAP12 and FcRγ are mediated by the transcription factor RBP-J, as deletion of Rbpj in these mice substantially rescued the defects of bone remodeling. Using a TNF-α-induced model of inflammatory bone resorption, we determined that RBP-J deficiency enables TNF-α to induce osteoclast formation and bone resorption in DAP12-deficient animals. Thus, RBP-J imposes a requirement for ITAM-mediated costimulation of RANKL or TNF-α-induced osteoclastogenesis. Mechanistically, RBP-J suppressed induction of key osteoclastogenic factors NFATc1, BLIMP1, and c-FOS by inhibiting ITAM-mediated expression and function of PLCγ2 and activation of downstream calcium-CaMKK/PYK2 signaling. Moreover, RBP-J suppressed Plcg2 expression and downstream calcium oscillations indirectly by a TGF-β/PLCγ2/calcium axis. Together, our findings indicate that RBP-J suppresses ITAM-mediated costimulation, thereby limiting crosstalk between ITAM and RANK/TNFR signaling and allowing fine tuning of osteoclastogenesis during bone homeostasis and under inflammatory conditions. Furthermore, these data suggest that environmental cues that regulate RBP-J expression/function potentially modulate the requirement for costimulatory signaling for osteoclast differentiation and bone remodeling.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25329696      PMCID: PMC4347236          DOI: 10.1172/JCI71882

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   19.456


  65 in total

1.  Amplification of IFN-alpha-induced STAT1 activation and inflammatory function by Syk and ITAM-containing adaptors.

Authors:  Ioannis Tassiulas; Xiaoyu Hu; Hao Ho; Yogita Kashyap; Paul Paik; Yongmei Hu; Clifford A Lowell; Lionel B Ivashkiv
Journal:  Nat Immunol       Date:  2004-10-03       Impact factor: 25.606

Review 2.  Osteoclasts and arthritis.

Authors:  Georg Schett; Steven L Teitelbaum
Journal:  J Bone Miner Res       Date:  2009-07       Impact factor: 6.741

Review 3.  New regulation mechanisms of osteoclast differentiation.

Authors:  Tomoki Nakashima; Hiroshi Takayanagi
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

4.  Factor recruitment and TIF2/GRIP1 corepressor activity at a collagenase-3 response element that mediates regulation by phorbol esters and hormones.

Authors:  I Rogatsky; K A Zarember; K R Yamamoto
Journal:  EMBO J       Date:  2001-11-01       Impact factor: 11.598

5.  OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and mice.

Authors:  Alexander David Barrow; Nicolas Raynal; Thomas Levin Andersen; David A Slatter; Dominique Bihan; Nicholas Pugh; Marina Cella; Taesoo Kim; Jaerang Rho; Takako Negishi-Koga; Jean-Marie Delaisse; Hiroshi Takayanagi; Joseph Lorenzo; Marco Colonna; Richard W Farndale; Yongwon Choi; John Trowsdale
Journal:  J Clin Invest       Date:  2011-08-15       Impact factor: 14.808

Review 6.  The molecular understanding of osteoclast differentiation.

Authors:  Masataka Asagiri; Hiroshi Takayanagi
Journal:  Bone       Date:  2006-11-13       Impact factor: 4.398

7.  The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase.

Authors:  Attila Mócsai; Mary Beth Humphrey; Jessica A G Van Ziffle; Yongmei Hu; Andrew Burghardt; Steven C Spusta; Sharmila Majumdar; Lewis L Lanier; Clifford A Lowell; Mary C Nakamura
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-08       Impact factor: 11.205

Review 8.  Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment.

Authors:  Georg Schett; Ellen Gravallese
Journal:  Nat Rev Rheumatol       Date:  2012-09-25       Impact factor: 20.543

9.  Integrated regulation of Toll-like receptor responses by Notch and interferon-gamma pathways.

Authors:  Xiaoyu Hu; Allen Y Chung; Indira Wu; Julia Foldi; Janice Chen; Jong Dae Ji; Tomoko Tateya; Young Jun Kang; Jiahuai Han; Manfred Gessler; Ryoichiro Kageyama; Lionel B Ivashkiv
Journal:  Immunity       Date:  2008-10-30       Impact factor: 31.745

10.  'Tuning' of type I interferon-induced Jak-STAT1 signaling by calcium-dependent kinases in macrophages.

Authors:  Lu Wang; Ioannis Tassiulas; Kyung-Hyun Park-Min; Alicia C Reid; Hava Gil-Henn; Joseph Schlessinger; Roland Baron; J Jillian Zhang; Lionel B Ivashkiv
Journal:  Nat Immunol       Date:  2007-12-16       Impact factor: 25.606

View more
  33 in total

1.  IL-1R/TLR2 through MyD88 Divergently Modulates Osteoclastogenesis through Regulation of Nuclear Factor of Activated T Cells c1 (NFATc1) and B Lymphocyte-induced Maturation Protein-1 (Blimp1).

Authors:  Zhihong Chen; Lingkai Su; Qingan Xu; Jenny Katz; Suzanne M Michalek; Mingwen Fan; Xu Feng; Ping Zhang
Journal:  J Biol Chem       Date:  2015-10-19       Impact factor: 5.157

Review 2.  Does TNF Promote or Restrain Osteoclastogenesis and Inflammatory Bone Resorption?

Authors:  Baohong Zhao
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

Review 3.  TNF and Bone Remodeling.

Authors:  Baohong Zhao
Journal:  Curr Osteoporos Rep       Date:  2017-06       Impact factor: 5.096

4.  Def6 Restrains Osteoclastogenesis and Inflammatory Bone Resorption.

Authors:  Nikolaus Binder; Christine Miller; Masaki Yoshida; Kazuki Inoue; Shinichi Nakano; Xiaoyu Hu; Lionel B Ivashkiv; Georg Schett; Alessandra Pernis; Steven R Goldring; F Patrick Ross; Baohong Zhao
Journal:  J Immunol       Date:  2017-03-17       Impact factor: 5.422

5.  NFAM1 signaling enhances osteoclast formation and bone resorption activity in Paget's disease of bone.

Authors:  Yuvaraj Sambandam; Kumaran Sundaram; Takamitsu Saigusa; Sundaravadivel Balasubramanian; Sakamuri V Reddy
Journal:  Bone       Date:  2017-05-12       Impact factor: 4.398

6.  C/EBPα transcription factor is regulated by the RANK cytoplasmic 535IVVY538 motif and stimulates osteoclastogenesis more strongly than c-Fos.

Authors:  Joel Jules; Wei Chen; Xu Feng; Yi-Ping Li
Journal:  J Biol Chem       Date:  2017-11-09       Impact factor: 5.157

7.  Editorial: Inflammatory Osteoclasts: A Different Breed of Bone Eaters?

Authors:  Deborah Veis Novack
Journal:  Arthritis Rheumatol       Date:  2016-12       Impact factor: 10.995

8.  RANK-Independent Osteoclast Formation and Bone Erosion in Inflammatory Arthritis.

Authors:  William O'Brien; Brian M Fissel; Yukiko Maeda; Jing Yan; Xianpeng Ge; Ellen M Gravallese; Antonios O Aliprantis; Julia F Charles
Journal:  Arthritis Rheumatol       Date:  2016-12       Impact factor: 10.995

9.  Identification of a Novel Role for Foxo3 Isoform2 in Osteoclastic Inhibition.

Authors:  Cheng Xu; Gregory J Vitone; Kazuki Inoue; Courtney Ng; Baohong Zhao
Journal:  J Immunol       Date:  2019-09-20       Impact factor: 5.422

Review 10.  A Comprehensive Review of Immunoreceptor Regulation of Osteoclasts.

Authors:  Mary Beth Humphrey; Mary C Nakamura
Journal:  Clin Rev Allergy Immunol       Date:  2016-08       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.